|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Diseases of poverty and the 10/90 Gap
The "10/90 Gap" is shorthand for the premise that only 10% of global pharmaceutical research funding is devoted to conditions accounting for 90% of the global disease burden. The rest goes to research on “lifestyle” diseases afflicting wealthy nations. This would be a damning accusation if it was true, but a new report from the Campaign for Fighting Diseases shows that the 10/90 Gap is a myth, and that it is often government policies in poor nations that deny their own citizens access to essential medicines.
|home spotlight commentary research events news about contact links archives|